Search the Newsreel

Sol Gel Technologies Ltd (SLGL) Financial Health: Profitability & Balance Sheet Analysis

Sol Gel Technologies Ltd (SLGL) has a financial score of 6.23, ranking 272 out of 384 in the Biotechnology & Medical Research industry, indicating robust financial status but low operating efficiency. The company's latest quarterly revenue decreased by 89.52% year-over-year to $108.00K, and net …

Sol Gel Technologies Ltd (SLGL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Sol Gel Technologies Ltd (SLGL), indicating its current valuation score is 9.47 and ranks 16th within the Biotechnology & Medical Research industry. It details the company's current P/E ratio, noting its deviation from recent highs and lows. …

SLGL|Sol Gel Technologies Ltd|Price:82.730|Chg%:-2.460

This article provides a comprehensive stock analysis of Sol Gel Technologies Ltd (SLGL), highlighting its strong fundamentals, high growth potential, and current "fairly valued" status. Institutional ownership is noted as very high, and analysts have issued "Buy" ratings with a high price target. While …

Sol-Gel Technologies Market Sentiment

This article provides an overview of market sentiment for Sol-Gel Technologies (SLGL), including analyst consensus, short interest, options flow, and insider activity. Analysts rate SLGL as "Outperform" with an average price target of $133, while short interest is declining, considered a bullish signal. Insider …

Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Sol Gel Technologies Ltd (SLGL), detailing its volatility, financial, and investment risks. The company's beta value is 1.15, indicating higher volatility compared to the S&P 500. Key metrics like maximum drawdown, Sharpe ratio, and daily returns over …

Sol Gel Technologies Ltd (SLGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses Sol Gel Technologies Ltd (SLGL)'s revenue breakdown by business segments and regional contributions. However, it explicitly states that the relevant data for these categories have not yet been disclosed by the company. The page provides general stock information for SLGL, including …

Sol Gel Technologies Ltd (SLGL) Cash Flow

This article provides the cash flow statement for Sol Gel Technologies Ltd (SLGL), detailing its operating, investing, and financing cash flows on both a quarterly and annual basis. It includes historical data from FY2016Q3 to FY2017Q4 and defines various cash flow metrics. The article …

Sol Gel Technologies Ltd (SLGL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sol Gel Technologies Ltd (SLGL), identifying major shareholders and institutional holdings. It provides a breakdown of ownership percentages by both specific entities like M.Arkin Dermatology Ltd and Opaleye Management Inc., and by shareholder types such as corporations …

Sol Gel Technologies Ltd (SLGL) Institutional Confidence

This article provides details on the institutional confidence in Sol Gel Technologies Ltd (SLGL), including a breakdown of major institutional shareholders and changes in their holdings. The data, updated on July 24, 2026, shows M.Arkin Dermatology, Ltd. as the largest holder, while Arkin (Moshe) …

SLGL Income Statement

This article provides the quarterly and annual income statements for Sol Gel Technologies Ltd (SLGL), offering detailed financial data such as total revenue, operating expenses, operating profit, net income, and earnings per share. It also includes an FAQ section explaining how to interpret the …

HC Wainwright Issues Positive Estimate for SLGL Earnings

H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target

H.C. Wainwright has reiterated a Buy rating and a $110 price target on Sol Gel Technologies Ltd. (NASDAQ:SLGL), highlighting SGT-610 (patidegib) as the company's primary value driver. This topical treatment for Gorlin syndrome is expected to have Phase 3 trial data in late 2026, …

SLGL Reiterated by HC Wainwright & Co. -- Rating Remains Buy

HC Wainwright & Co. has reiterated its Buy rating for Sol-Gel Technologies (SLGL), maintaining a price target of $110.00, despite GuruFocus indicating the stock is approximately 25.7% overvalued. The company's GF Score is 54/100, showing strong financial strength but weaker profitability and growth. Recent …

HC Wainwright Reiterates "Buy" Rating for Sol-Gel Technologies (NASDAQ:SLGL)

SLGL Forecast — Price Target — Prediction for 2027

Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates

Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Sol-Gel Technologies (SLGL) Earnings Date and Reports 2026 $SLGL